UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer
March 20, 2018 at 03:05 AM EDT
ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not yet show an overall survival benefit in this tough-to-treat disease, the Swiss drugmaker said Tuesday.
